Stem Cell Educator therapy

COMBINATION_PRODUCT4 trials

Sponsors

Hackensack Meridian Health, Throne Biotechnologies Inc.

Conditions

Alopecia AreataAlopecia TotalisAlopecia UniversalisDiabetes Mellitus Type 1Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Type 1 Diabetes

Phase 1

A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes

CompletedNCT02624804

Hackensack Meridian HealthDiabetes Mellitus Type 1

Start: 2017-06-27End: 2024-03-11Updated: 2026-04-03

Phase 2

Stem Cell Educator Therapy in Diabetes

Throne Biotechnologies Inc.Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2017-11-27End: 2020-12-31Target: 100Updated: 2019-02-05

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Throne Biotechnologies Inc.Alopecia Areata, Alopecia Totalis, Alopecia Universalis

Start: 2022-09-20End: 2023-07-30Target: 20Updated: 2023-01-12

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

RecruitingNCT04011020

Throne Biotechnologies Inc.Type 1 Diabetes

Start: 2022-09-20End: 2025-06-20Target: 50Updated: 2024-04-29